Randomized Phase II/III Study of DA-EPOCH-R +/- Venetoclax in Previously Untreated Double Hit Lymphoma: Initial Results from Alliance A051701
- Citation:
- Blood vol 138 (Supplement 1) 523
- Meeting Instance:
- ASH 2021
- Year:
- 2021
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 and UG1CA232760 (ECOG-ACRIN)
- Corr. Author:
- Authors:
- Jeremy S. Abramson Amy S. Ruppert Sharmila Giri Ann Hudson Eric Hsi Richard Little Steven Gore Anusha Vallurupalli Daniel Landsburg Brad Kahl Jonathan Friedberg Nancy L. Bartlett John P. Leonard
- Networks:
- LAPS-MA036, LAPS-MN026, LAPS-MO011, MD001, NY018, OR013, PA121
- Study
- Alliance-A051701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: